title: The biological basis of severe outcomes in Anaplasma phagocytophilum infection.
abstract: Anaplasma phagocytophilum causes granulocytic anaplasmosis, an acute disease in humans that is also often subclinical. However, 36% are hospitalized, 7% need intensive care, and the case fatality rate is 0.6%. The biological basis for severe disease is not understood. Despite A. phagocytophilum's mechanisms to subvert neutrophil antimicrobial responses, whether these mechanisms lead to disease is unclear. In animals, inflammatory lesions track with IFNγ and IL-10 expression and infection of Ifng(-/-)  mice leads to increased pathogen load but inhibition of inflammation. Suppression of STAT signaling in horses impacts IL-10 and IFN-γ expression, and also suppresses disease severity. Similar inhibition of inflammation with infection of NKT-deficient mice suggests that innate immune responses are key for disease. With severe disease, tissues can demonstrate hemophagocytosis, and measures of macrophage activation/hemophagocytic syndromes (MAS/HPS) support the concept of human granulocytic anaplasmosis as an immunopathologic disease. MAS/HPS are related to defective cytotoxic lymphocytes that ordinarily diminish inflammation. Pilot studies in mice show cytotoxic lymphocyte activation with A. phagocytophilum infection, yet suppression of cytotoxic responses from both NKT and CD8 cells, consistent with the development of MAS/HPS. Whether severity relates to microbial factors or genetically determined diversity in human immune and inflammatory response needs more investigation.
authors.affiliation: Department of Pathology, The Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA. sdumler@jhmi.edu
authors.forename: J Stephen
authors.initials: JS
authors.lastname: Dumler
mesh_terms: D041081:Anaplasma phagocytophilum / Q000276:immunology* / Q000302:isolation & purification / Q000472:pathogenicity*; D000818:Animals; D004195:Disease Models, Animal; D016873:Ehrlichiosis / Q000382:microbiology* / Q000401:mortality / Q000473:pathology*; D006801:Humans; D007113:Immunity, Innate; D012720:Severity of Illness Index; D015398:Signal Transduction; D016896:Treatment Outcome
references.citation: Emerg Infect Dis. 2008 Jun;14(6):938-40
references.pmid: 18507907
references.citation: Ann N Y Acad Sci. 2003 Jun;990:488-93
references.pmid: 12860678
references.citation: Infect Immun. 2008 Jan;76(1):308-16
references.pmid: 17998313
references.citation: Clin Vaccine Immunol. 2007 Oct;14(10):1260-5
references.pmid: 17687112
references.citation: Infect Agents Dis. 1995 Sep;4(3):167-70
references.pmid: 8548195
references.citation: Infect Immun. 2007 Jun;75(6):3124-30
references.pmid: 17403880
references.citation: Infect Dis Clin North Am. 2008 Sep;22(3):433-48, viii
references.pmid: 18755383
references.citation: J Infect Dis. 2000 Jan;181(1):374-8
references.pmid: 10608792
references.citation: Clin Infect Dis. 1998 Dec;27(6):1491-6
references.pmid: 9868666
references.citation: Curr Opin Hematol. 2008 Jul;15(4):359-67
references.pmid: 18536575
references.citation: Infect Immun. 2004 Aug;72(8):4772-83
references.pmid: 15271939
references.citation: J Exp Med. 1993 Aug 1;178(2):567-77
references.pmid: 8101861
references.citation: Curr Opin Hematol. 2006 Jan;13(1):28-33
references.pmid: 16319684
references.citation: Clin Infect Dis. 2000 Aug;31(2):554-60
references.pmid: 10987720
references.citation: PLoS Pathog. 2009 Jun;5(6):e1000488
references.pmid: 19543390
references.citation: Infect Immun. 2009 Jun;77(6):2385-91
references.pmid: 19307214
references.citation: Clin Infect Dis. 2002 Jan 1;34(1):22-7
references.pmid: 11731941
references.citation: Am J Trop Med Hyg. 2000 Jan;62(1):29-37
references.pmid: 10761721
references.citation: J Immunol. 2002 Dec 15;169(12):7009-18
references.pmid: 12471136
references.citation: Clin Infect Dis. 2007 Jul 15;45(2):199-204
references.pmid: 17578779
references.citation: Clin Infect Dis. 2006 Nov 1;43(9):1089-134
references.pmid: 17029130
references.citation: J Pediatr. 2005 May;146(5):598-604
references.pmid: 15870661
references.citation: Trends Immunol. 2004 Jun;25(6):323-7
references.pmid: 15145322
references.citation: Infect Immun. 2000 Apr;68(4):1827-33
references.pmid: 10722570
references.citation: Clin Infect Dis. 1998 Dec;27(6):1424-7
references.pmid: 9868655
references.citation: Clin Microbiol Rev. 2011 Jul;24(3):469-89
references.pmid: 21734244
references.citation: Comp Med. 2006 Feb;56(1):55-62
references.pmid: 16521860
references.citation: Autoimmun Rev. 2004 Feb;3(2):69-75
references.pmid: 15003190
references.citation: Trends Immunol. 2004 Dec;25(12):677-86
references.pmid: 15530839
references.citation: J Rheumatol. 2007 May;34(5):1133-8
references.pmid: 17343315
references.citation: Clin Infect Dis. 2001 Mar 15;32(6):862-70
references.pmid: 11247709
references.citation: Clin Diagn Lab Immunol. 2004 Sep;11(5):963-8
references.pmid: 15358660
references.citation: J Clin Invest. 2004 Nov;114(10):1379-88
references.pmid: 15545985
references.citation: Arthritis Rheum. 2004 Mar;50(3):689-98
references.pmid: 15022306
references.citation: Cell Microbiol. 2007 Nov;9(11):2644-57
references.pmid: 17587335
references.citation: J Infect Dis. 1999 Aug;180(2):546-50
references.pmid: 10395880
references.citation: Infect Immun. 2001 Sep;69(9):5577-88
references.pmid: 11500432
references.citation: Immunol Rev. 2005 Feb;203:165-79
references.pmid: 15661029
references.citation: JAMA. 1996 Jan 17;275(3):199-205
references.pmid: 8604172
references.citation: Am J Pathol. 2001 May;158(5):1881-8
references.pmid: 11337387
references.citation: Infect Immun. 2000 Jul;68(7):4361-2
references.pmid: 10858261
references.citation: Annu Rev Immunol. 2005;23:877-900
references.pmid: 15771592
references.citation: Cell Microbiol. 2007 Jul;9(7):1730-7
references.pmid: 17346310
references.citation: Nature. 2005 Mar 24;434(7032):525-9
references.pmid: 15791258
references.citation: Clin Vaccine Immunol. 2011 Nov;18(11):1962-8
references.pmid: 21880854
references.citation: Immunobiology. 2005;210(2-4):63-76
references.pmid: 16164013
references.citation: Hematology Am Soc Hematol Educ Program. 2005;:82-8
references.pmid: 16304363
references.citation: Clin Infect Dis. 2007 Jul 15;45 Suppl 1:S45-51
references.pmid: 17582569
references.citation: Clin Diagn Lab Immunol. 2000 Jan;7(1):6-8
references.pmid: 10618268
references.citation: J Infect Dis. 2000 Apr;181(4):1388-93
references.pmid: 10751139
references.citation: FEMS Immunol Med Microbiol. 2007 Apr;49(3):374-86
references.pmid: 17286796
references.citation: Ann N Y Acad Sci. 2006 Oct;1078:236-47
references.pmid: 17114714
references.citation: J Infect Dis. 2000 Jul;182(1):200-5
references.pmid: 10882598
references.citation: JAMA. 2008 Nov 19;300(19):2263-70
references.pmid: 19017912
references.citation: Am J Med. 1997 Aug;103(2):114-20
references.pmid: 9274894
references.citation: J Infect Dis. 1998 Mar;177(3):737-45
references.pmid: 9498456
references.citation: Infect Immun. 2004 Sep;72(9):5392-401
references.pmid: 15322037
references.citation: J Immunol. 2003 Oct 15;171(8):4020-7
references.pmid: 14530322
references.citation: Clin Vaccine Immunol. 2008 Mar;15(3):418-24
references.pmid: 18094110
references.citation: Clin Vaccine Immunol. 2006 Jul;13(7):806-9
references.pmid: 16829620
references.citation: FEMS Microbiol Lett. 2002 Feb 5;207(2):111-20
references.pmid: 11958927
references.citation: MMWR Recomm Rep. 2006 Mar 31;55(RR-4):1-27
references.pmid: 16572105
references.citation: Emerg Infect Dis. 1996 Jan-Mar;2(1):18-29
references.pmid: 8903194
references.citation: J Immunol. 2000 Apr 15;164(8):3946-9
references.pmid: 10754283
references.citation: Emerg Infect Dis. 2005 Dec;11(12):1828-34
references.pmid: 16485466
references.citation: Nat Rev Immunol. 2006 Dec;6(12):940-52
references.pmid: 17124515
references.citation: Eur J Immunol. 2004 Jul;34(7):1789-97
references.pmid: 15214027
references.citation: J Leukoc Biol. 2003 Feb;73(2):209-12
references.pmid: 12554797
references.citation: Emerg Infect Dis. 2000 Nov-Dec;6(6):601-8
references.pmid: 11076718
references.citation: JAMA. 1994 Jul 20;272(3):212-8
references.pmid: 8022040
references.citation: Infect Immun. 2000 Jun;68(6):3394-402
references.pmid: 10816490